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Abstract
Background: The Notch signaling pathway regulates adult neurogenesis under physiological and pathophysiological
conditions. MicroRNAs are small non-coding RNA molecules that regulate gene expression. The present study investigated
the effect of miR-124a on the Notch signaling pathway in stroke-induced neurogenesis.
Methodology and Principal Findings: We found that adult rats subjected to focal cerebral ischemia exhibited substantial
reduction of miR-124a expression, a neuron specific miRNA, in the neural progenitor cells of the subventricular zone (SVZ) of
the lateral ventricle, which was inversely associated with activation of Notch signals. In vitro, transfection of neural
progenitor cells harvested from the SVZ of adult rat with miR-124a repressed Jagged-1 (JAG1), a ligand of Notch, in a
luciferase construct containing the JAG1 target site. Introduction of miR-124a in neural progenitor cells significantly reduced
JAG1 transcript and protein levels, leading to inactivation of Notch signals. Transfection of neural progenitor cells with miR-
124a significantly reduced progenitor cell proliferation and promoted neuronal differentiation measured by an increase in
the number of Doublecortin positive cells, a marker of neuroblasts. Furthermore, introduction of miR-124a significantly
increased p27Kip1 mRNA and protein levels, a downstream target gene of the Notch signaling pathway.
Conclusions: Collectively, our study demonstrated that in vivo, stroke alters miRNA expression in SVZ neural progenitor cells
and that in vitro, miR-124a mediates stroke-induced neurogenesis by targeting the JAG-Notch signaling pathway.
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Introduction
The Notch pathway is a highly conserved regulatory signaling
network [1] and has been linked to a variety of pathogenic
conditions in human [2]. The Notch signaling pathway critically
controls stem cell maintenance and cell fate determination [1], [3].
We and others have demonstrated that focal cerebral ischemia
activates the Notch signaling pathway in neural progenitor cells
localized to the subventricular zone (SVZ) of the lateral ventricle,
leading to expansion of neural progenitor cells [3], [4], [5], [6].
MicroRNAs (miRNAs) are small, single-stranded RNA mole-
cules of 21–23 nucleotides in length. miRNAs are encoded by
genes from whose DNA they are transcribed, but miRNAs are not
translated into protein; instead, each primary transcript (a pri-
miRNA) is processed into a short stem-loop structure called a pre-
miRNA and finally into a functional miRNA. Mature miRNA
molecules are either fully or partially complementary to one or
more messenger RNA (mRNA) molecules, and their main function
is to down-regulate gene expression [7]. miRNAs have been
recently shown to be crucial in regulating a variety of patho-
physiological processes, including immune function, tumorigene-
sis, metabolism, and cell proliferation [8], [9], [10].
A relatively large number of these miRNAs are enriched in the
brain [11]. Biological functions of brain miRNAs are emerging.
miRNAs regulate neuronal and glial development and differen-
tiation [12], [13]. MiR-124, a preferentially expressed miRNA in
neurons, has recently been implicated in the positive modulation
of the transitory progression of adult SVZ neurogenesis by
repressing Sox9 [14], indicating that this specific miRNA is
critical for the homeostasis of differentiation versus proliferation of
adult neural progenitor cells [14], [15].
Studies in cancer cells show that several miRNAs cross-talk with
the Notch pathway [16], [17], [18], [19], [20]. However, the role
of miRNAs in the Notch pathway after stroke remains unclear.
Understanding the interaction between miRNAs and the Notch
signaling pathway in adult neural progenitor cells after stroke
could potentially provide new therapies to enhance stroke-induced
neurogenesis. Accordingly, the present study investigated miRNAs
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23461in mediating the Notch signaling pathway in neural progenitor
cells after stroke.
Results
Stroke alters miRNA expression in SVZ neural progenitor
cells
To examine the expression profile of miRNAs after focal
cerebral ischemia, we analyzed the global expression of mature
miRNAs in cultured neural progenitor cells isolated from the SVZ
in rats 7 days after right middle cerebral artery occlusion (MCAo,
n=3 individual cultured SVZ cells, Table S1). SVZ neural
progenitor cells isolated from non-ischemic rats were used as a
control group (n=3). miRNA microarray platform was used to
screen the expression profiles of miRNAs (Fig. 1A–1C, for more
detailed, please see Figure S1). We found that 38 and 48 miRNAs
in ischemic neural progenitor cells were at least 1.5 fold
upregulated and 1.5 fold downregulated, respectively (P,0.05,
Table S1). Among them, 18 of these were found to be poorly
expressed, whereas 21 of these were highly abundant in the
ischemic neural progenitor cells with 2 fold or greater changes
(P,0.01, Fig. 2A).
To analyze the likely role of these miRNAs in neural progenitor
cells, a biological function analysis was performed on the miRNAs
in the SVZ cells, which were de-regulated more than two fold with
ap ,0.01 (Fig. 2A). Twenty-one upregulated miRNAs and
eighteen downregulated miRNAs were chosen for further pathway
analysis using DIANA – mirPath software (http://diana.cslab.ece.
ntua.gr/pathways/) [21]. The top 10 ranked biologic functions
associated with commonly upregulated miRNAs include regula-
tion of axon guidance, the MAPK signaling pathway, focal
adhesion, ErbB signaling pathway, actin cytoskeleton, Wnt
signaling pathway, GnRH signaling pathway, insulin signaling
pathway, glioma, and renal cell carcinoma (Table S2). The top 10
ranked biologic functions associated with commonly downregu-
lated miRNAs included axon guidance, the MAPK signaling
pathway, pancreatic cancer, focal adhesion, renal cell carcinoma,
TGF-beta signaling pathway, insulin signaling pathway, Wnt
signaling pathway, mTOR signaling pathway, prostate cancer,
adhere junction, the ErbB signaling pathway, glioma, and
regulation of actin cytoskeleton (Table S2).
Validation of miRNA expression in SVZ neural progenitor
cells after MCAo
Using Taqman probes and quantitative real-time RT-PCR
(qPCR), which detect mature miRNAs, we verified the most
altered miRNAs detected on the microarray in neural progenitor
cells after MCAo (Fig. 2B and 2C). Among them, miR-124a was
significantly decreased in ischemic SVZ neural progenitor cells.
Since there may be biological differences between cells obtained in
vivo and from cultures, we analyzed miRNA profiles in SVZ
neural progenitor cells isolated from the brain tissue by laser
capture microdissection (LCM, Fig. 3A and B) and found a
significant reduction of miR-124a in these cells 7 days after stroke
(Fig. 3C). In addition, the neural progenitor cells isolated by LCM
exhibited increases in miR-146a, miR-146b, miR-210, miR-19b
and miR-378 and decreases in miR-128, miR-291a-3p, and miR-
139-5p (Fig. 3A to 3C), which are consistent with the array data
findings. Although there is magnitude discrepancy of gene
expression between the array and PCR data for miRNAs listed
above, both methods demonstrated that stroke significantly change
miRNA expression. In addition to differences between SVZ cells
isolated from ex vivo and cultured SVZ cells, one of the reasons for
the discrepancy may lie in the different platforms employed to
detect different miRNA amplicons [22].
MiR-124a in SVZ progenitor cells mediates
stroke-induced neurogenesis
In situ hybridization with digoxigenin (DIG)-labeled LNA
probes that target the mature form of miR-124a shows the
presence of miR-124a signals in non-ischemic SVZ cells (Fig. 3D),
which is consistent with a published study [14]. However, 7 day
ischemia substantially reduced miR-124a in SVZ cells (Fig. 3E, F)
compared to miR-124a signals in the contralateral SVZ (Fig. 3D,
F), which is concomitant with substantial increases in neural
progenitor cell proliferation 7 days after stroke, as previously
demonstrated [5], [23]. These data suggest that miR-124a could
regulate progenitor cell proliferation after stroke. We therefore,
examined the effect of delivery of miR-124a on neural progenitor
cell proliferation.
To deliver miRNA into neural progenitor cells, a newly
developed nanoparticle-mediated method was employed [24],
To verify the delivery efficiency of nanoparticles, miR mimic
indicator (cel-miR-67) which was conjugated with Dye548 was
introduced into SVZ neural progenitor cells and approximately
90% progenitor cells were observed to be red fluorescence 10 h
after delivery (Fig. 4A). However, no cell exhibited red
fluorescence in the absence of nanoparticles, suggesting the
specific and efficient delivery of miRNA into progenitor cells by
nanoparticles (Fig. 4B). In addition, introduction of nanoparticles
to SVZ cells did not cause an increase in TUNEL positive cells
compared with SVZ cells without introduction of nanoparticles
(data not shown). We then delivered nanoparticles with miR-124a
mimics into ischemic SVZ neural progenitor cells. Using a
neurosphere assay in which single ischemic SVZ cells (10 cells/ml)
were incubated in the growth medium, we examined the effect of
miR-124a on cell proliferation. Introduction of miR-124a mimics
in ischemic neural progenitor cells significantly (P,0.05) de-
creased the numbers and size of neurospheres (Fig. 4C–4F) and
the number of BrdU-positive cells (Fig. 4G–M) compared with
cells delivered with miRNA mimic controls. Together, these results
showed that nanoparticle-delivered miR-124a suppressed ische-
mia-induced progenitor cell proliferation.
To examine the effect of miR-124a on progenitor cell
differentiation, SVZ cells after introduction of miR-124a mimics
or mimic controls were cultured under the differentiation media.
Real-time RT-PCR analysis revealed that introduction of miR-
124a strikingly increased the expression of DCX (4.560.3 vs
1.060.2 in the control, n=3, p,0.05), a marker of migrating
neuroblasts, but did not significantly affect GFAP mRNA levels
compared with the cells transfected with mimic controls (1.360.2
vs 1.060.2 in the control, n=3, p.0.05). Consistent with mRNA
results, introduction of miR-124a mimics into SVZ neural
progenitor cells isolated from the DCX-eGFP transgenic mouse
resulted in two fold increases in DCX-eGFP neurospheres in the
differentiation medium (9.563.6% in miR-124a group vs
5.162.9% mimic control group, n=12, Fig. 4N and O,
p,0.05). These data suggest that increases of miR-124a promote
neuronal differentiation.
MiR-124a regulates Notch signaling pathway
Previous studies have shown that under non-ischemic condi-
tions, miR-124 targets Sox9, JAG1 and DLX2, and that miR-124
mediates neurogenesis by repressing Sox9 in SVZ cells [14], [25].
However, stroke did not significantly increase Sox9 levels in SVZ
neural progenitor cells (1.260.2 in ischemic vs 1.060.1 in non-
ischemic, n=3, p=0.23). JAG1 is a ligand of the transmembrane
MiR-124a Regulates Neurogenesis Induced by Stroke
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mediates stroke-induced neurogenesis [1], [4], [5], [6]. The role
of miR-124a in mediating the Notch signaling pathway has not
been investigated in ischemic neural progenitor cells. Our real-
time RT-PCR and Western blot analysis showed that stroke
increased JAG1 mRNA and protein levels in SVZ neural
progenitor cells, which was negatively correlated with miR-
124a signals (Fig. 5A, B, C and Fig. 2). To further validate this
computational finding that miR-124a may negatively regulate
JAG1, we generated a luciferase construct harboring the 39-UTR
fragment of JAG1 containing a broadly conserved binding site of
miR-124a (Luc-JAG1, Fig. 5D) and a mutant luciferase construct
with deletion of the binding site (Luc-JAG1-mu, Fig. 5D).
Luciferase assay showed that miR-124a significantly repressed
the luciferase activity in the 3T3 cell line transiently transfected
with Luc-JAG1, compared with cells transfected with Luc-JAG1-
mu (Fig. 5E), which is consistent with previous findings that JAG1
is a putative target of miR-124a [14].
We then examined the effect of miR-124a on JAG1
expression in ischemic SVZ neuralp r o g e n i t o rc e l l s .I s c h e m i c
progenitor cells were delivered with miR-124a mimics and
incubated in the growth medium for 3 days. JAG1 and Notch
intracellular domain (NICD) were assayed by real-time RT-
PCR and Western blot. Compared with the miRNA mimic
control, nanoparticle-delivered mature miR-124a resulted in a
substantial decrease of JAG1 transcript and protein (Fig. 5F and
G). Introduction of miR-124a also substantially decreased
NICD levels (Fig. 5H) compared with the mimic control group.
Furthermore, introduction of miR-124a mimics increased
p27Kip1 transcripts approximately 6.7 fold (Fig. 5I) and protein
expression about 1.3 fold (Fig. 5J), compared with the miRNA
mimic control group, which is consistent with previous findings
Figure 1. MicroRNA expression in SVZ neural progenitor cells. Hierarchical clustering of differentially expressed miRNAs (A, B). The data were
from 6 individual microarrays (3 arrays per group). The individual expression signal of each miRNA in each array was clustered. The dendrograms (tree
diagrams) show the grouping of miRNAs according to the order in which they were joined during the clustering. The color code in the heat maps is
linear with green as the lowest and red as the highest. The miRNAs with increased expression are shown in red (A), whereas the miRNAs with
decreased expression are shown in green (B). Correlation of the hybridization signal intensities of all the expressed miRNAs among three non-MCAo
samples and MCAo showed few differences(C).
doi:10.1371/journal.pone.0023461.g001
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pathway [27], [28]. Collectively, these data indicate that miR-
124a targets the JAG1-Notch signaling pathway in ischemic
neural progenitor cells.
In addition, real-time RT-PCR and Western blot analysis
showed that DLX2, a homeobox gene [29], mRNA and protein
levels, respectively, were greatly increased in ischemic SVZ neural
progenitor cells, which were concurrent with downregulation of
miR-124a level (Fig. 5K and L). Introduction of miR-124a mimics
into ischemic neural progenitor cells significantly decreased levels
of mRNA and DLX2 protein (Fig. 5M and N).
Discussion
We demonstrated that stroke altered expression profiles of
multiple miRNAs in SVZ neural progenitor cells and that
introduction of miR-124a inhibited ischemic neural progenitor
cell proliferation and promoted the neuronal differentiation of the
progenitor cells by targeting JAG1. These data provide new
insights into the molecular mechanisms underlying stroke-induced
neurogenesis.
MicroRNAs regulate biological function of neural stem cells in
developing and adult CNS [11], [12], [13], [14]. However, the
Figure 2. Validation of top differential expressions of miRNAs. Microarray data (A) show 18 and 21 of miRNAs with 2 fold changes (p,0.01)
were found to be poorly and highly expressed, respectively, in ischemic neural progenitor cells (MCAo). N=3 individual cultured SVZ cells/group.
Real-time RT-PCR analysis shows ten of increased (B) and decreased (C) miRNAs detected on the microarray. Data are mean 6 SE. N=4–6 individual
cultured SVZ cells/group.
doi:10.1371/journal.pone.0023461.g002
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been investigated. The present study showed that stroke
substantially altered expression profiles of miRNAs in SVZ neural
progenitor cells and that many of the altered miRNAs could
potentially regulate the MAPK and Wnt signaling pathways
known to regulate neurogenesis. These data suggest that miRNAs
are actively involved in stroke-induced neurogenesis and our data
also provide bases to further investigate biological function of the
altered miRNAs in stroke-induced neurogenesis.
MiR-124 is a neuron-specific miRNA and regulates neurogen-
esis in SVZ neural progenitor cells of adult normal mice [14], [15],
[30], [31]. Our in vivo and in vitro data showed that down-
regulation of miR-124a by stroke enhances progenitor cell
proliferation, while introduction of miR-124a attenuates stroke-
increased proliferation and increases neuronal differentiation,
indicating that miR-124a in SVZ neural progenitor cells could
mediate stroke-induced neurogenesis. Under non-ischemic condi-
tions, miR-124 promotes transition from the transit amplifying
SVZ progenitor cells to the neuroblasts by physiologically
targeting Sox9 [14], [25]. Sox9 is required for the generation
and maintenance of adult SVZ neural stem cells [32]. However,
the present study showed that stroke did not significantly change
Sox9 expression. Instead, our data provide several lines of
evidence to demonstrate that in vitro, miR-124a mediates
stroke-induced neurogenesis by targeting the JAG1 in neural
progenitor cells. Introduction of miR-124a mimics suppressed
JAG1 expression, whereas mutation of the JAG1 binding site
abolished the effect of miR-124a on JAG1 expression. There are
two predicted targets in the full length 39-UTR of JAG1 (www.
targetscan.org). Published data show that miR-124a significantly
decreased luciferase activity in 39-UTR of JAG1, which includes
two target sites [14]. Thus, the effect of miR-124a on JAG1 is
specific. In addition, introduction of miR-124a attenuated
activation of NICD and upregulated p27Kip1, a target gene of
Notch signaling pathway, indicating that miR-124a mediates
activation of the Notch pathway. The Notch receptors are
transmembrane proteins activated by Delta and JAG ligands
[26]. The Notch signaling pathway is essential to maintain the
SVZ neural stem cell niche of adult rodent [33]. We and others
previously demonstrated that the Notch signaling pathway
mediates stroke-induced neurogenesis [3], [5], [6]. Activation of
Notch signals by stroke increases proliferation of SVZ neural
progenitor cells, while down-regulation of the Notch signals
promotes neural progenitor cell differentiation into neuroblasts
[5], [6]. Administration of a Notch ligand, Dll4, increases
neurogenesis in the ischemic brain [3]. We now demonstrate that
miR-124a regulates activation of the Notch signaling pathway in
SVZ neural progenitor cells. However, in vivo experiments are
warranted to demonstrate the cause effect of miR-124a through
targeting JAG1 on stroke-induced neurogenesis, although our in
vivo data showed that down-regulation of miR-124a by stroke was
inversely correlated to upregulation of JAG1. In addition to miR-
124a, stroke downregulates miR-9 and miR-139 in neural
progenitor cells and these miRNAs have been predicted to target
Notch and Hes1 [34] (www.targetscan.org), suggesting that miR-
9 and miR-139 could also regulate the Notch signaling pathway
Figure 3. Expression of miRNAs in vivo. Panels A and B show SVZ cells before (A) and after (B) laser capture microdissection (LCM).
Panel C shows real-time RT-PCR results of miRNA expressions in non-ischemic (non-MCAo) and ischemic (MCAo) SVZ cells isolated by LCM. N=4–6
rats/group. In situ hybridization with digoxigenin (DIG)-labeled RNA probes shows miR-124a signals in non-ischemic (D, outlines) and ischemic (E,
outlines) SVZ. Panel F shows quantitative data of miR-124a. CC=corpus callosum; LV=lateral ventricle; Str=striatum; SVZ=subventricular zone. N=5
rats/group. Scale bar=40 mm.
doi:10.1371/journal.pone.0023461.g003
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[19], let-7 [35] have been shown to regulate the Notch signaling
pathway. Therefore, we expect that there are multiple miRNAs
acting in concert with miR-124a to fine-tune the Notch pathway
in stroke-induced neurogenesis.
The homeobox transcription factor DLX2 regulates generation
of interneurons in the embryo [36] and promotes neurogenesis in
the postnatal SVZ [37]. The present study showed that stroke
upregulated DLX2, which was concurrently with reduction of
miR-124a, whereas miR-124a mimics reduced DLX2 expression
in ischemic neural progenitor cells. MiR-124 targets DLX2 [14].
Thus, downregulation of miR-124a by stroke could upregulate
DLX2 expression, leading to proliferation of SVZ neural
progenitor cells. In general, miRNAs can regulate numerous
target mRNAs at the post-transcriptional level [38], [39]. Data are
emerging that some individual miRNAs also regulate target
mRNAs at transcriptional levels [40], [41]. Whether miR-124
regulates JAG1 at the transcriptional level is warranted for future
studies.
In addition to its role in neurogenesis, upregulation of miR-124
suppresses development of autoimmune encephalomyelitis by
inactivation of macrophages [42]. Inflammation contributes to
ischemic cell damage [43]. Ischemia substantially changes miRNA
expression profiles during the acute stage [44], [45], [46], [47].
Inhibition of miR-145 and upregulation of miR-21 have
neuroprotective effects [46], [48]. Thus, investigation of the effects
of miR-124 on inflammation in the ischemic brain is warranted.
In summary, our study revealed the cell–specific pattern of
miRNAs in SVZ neural progenitor cells after stroke. Downregu-
lation of miR-124a induces JAG1 expression in the SVZ neural
progenitor cells after stroke and thereby promotes neural progenitor
cell proliferation. As neurogenesis is related to the behavioral
recovery of stroke [49], miR-124a could potentially be used as a
therapeutic target to amplify endogenous neurogenesis after stroke.
Materials and Methods
All experimental procedures were carried out in accordance
with the NIH Guide for the Care and Use of Laboratory Animals
and approved by the Institutional Animal Care and Use
Committee of Henry Ford Hospital (IACUC approval number:
1069).
Animal model of middle cerebral artery occlusion (MCAo)
Male Wistar rats (3–4 months) were employed in this study. The
right middle cerebral artery (MCA) was occluded by placement of
an embolus at the origin of the right MCA, as previously described
[50]. In this model, MCA occlusion (MCAo) evokes a peak
increase of neurogenesis 7 days after stroke [51]. Therefore, all rats
were sacrificed 7 days after MCAo.
Figure 4. The effect of miR-124a on proliferation and differentiation of neural progenitor cells. Microscopic images acquired under
fluorescent and bright fields after introduction of miRNA mimic indicator conjugated with Dy547 show more than 90% SVZ neural progenitor cells
exhibiting red fluorescence, indicating robust delivery efficiency (A). No red fluorescence was observed in SVZ neural progenitor cells in the presence
of miRNA mimic indicator but without nanoparticles (B). Panels C and D show neurospheres cultured in the proliferation medium after introduction
of miR mimic controls (C) and miR-124a mimics (D), while panels E and F show quantitative data of number (E) and size (F) of neurospheres delivered
with mimic controls (control) or miR-124a mimics (miR-124a) in the proliferation medium. Panels G to M show BrdU immunoreactive cells after
transfection with miRNA mimic controls (G to I, and M) and miR-124a mimics (J to L, and M). Panels N and O show DCX-EGFP SVZ cells cultured in the
differentiation medium after introduction of miRNA mimic controls (N) and miR-124a mimics (O). Scale bar=100 mm in D and 20 mm in L and O.
doi:10.1371/journal.pone.0023461.g004
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eGFP) mouse line was purchased from the Mutant Mouse
Regional Resource Center. We have verified specificity of DCX-
eGFP expressing cells in the adult DCX–eGFP SVZ [23], [52].
SVZ cell culture
SVZ neural progenitor cells were isolated from adult rats and
DCX–EGFP mice, as previously described [5], [53]. The cells
were plated at a density of 2610
4 cells/ml in the growth medium,
which contains DMEM/F-12 medium (Invitrogen Corporation,
Carlsbad, CA, USA), 20 ng/ml epidermal growth factor (R&D
Systems, Minneapolis, MN, USA), and basic fibroblast growth
factor (R&D Systems). DMEM/F-12 medium contains L-gluta-
mine (2 mmol/liter), glucose (0.6%), putrescine (9.6 mg/ml),
insulin (0.025 mg/ml), progesterone (6.3 ng/ml), apotransferrin
(0.1 mg/ml), and sodium selenite (5.2 ng/ml). The generated SVZ
neurospheres (primary spheres) were passaged by mechanical
dissociation and reseeded as single cells at a density of 20 cells/ml.
Passaged 1 SVZ cells were employed for assay of the miRNA
array. Other experiments used cultured SVZ neural progenitor
cells which were passaged less than 5 to avoid the likely genetic
variation of progeny [54].
miRNA array assay and analysis
Cultured SVZ cells isolated from 3 rats were pooled for each
miRNA array analysis and three individually cultured SVZ cells
were collected for non-MCAo and MCAo groups. Total RNAs
were extracted using mirVana
TM miRNA Isolation Kit (Applied
Biosystems, Foster City, CA, USA) in accordance with the
manufacturer’s procedure. RNA samples were analyzed by
Biomarker Incoporation (Precision Biomarker Resources Inc,
Evanston, IL, USA) using GeneChipH miRNA Array (Affymetrix
Inc, Santa Clara, CA, USA) containing 46,228 probes comprising
7,815 probe sets, including controls. Among them, 352 probe sets
Figure 5. miR-124a targets the 39-UTR of JAG1. Panel A shows sequence of a potential miR-124a binding site in the rat. Real-time RT-PCR (B)
and Western blot (C) show mRNA and protein levels, respectively, of JAG1 in non-ischemic (control) and ischemic (MCAo) SVZ neural progenitor cells.
Schematic representation (D) of a miR-124a reporter vector containing a CMV promoter driving the expression of luciferase cDNA fused to the JAG1
39-UTR (pMIR-JAG1-39-UTR) or to a mutated JAG1 39-UTR (pMIR-JAG1-mu-39-UTR). Panel E shows relative luciferase activity of constructs containing
the pMIR-JAG1-39-UTR or pMIR-JAG1-mu-39-UTR introduced into NIH 3T3 cells in the presence of miR-124a mimics and mimic controls. A pRL-TK
vector was transfected into the cells along with the pMIR-JAG1-39-UTR or pMIR-JAG1-mu-39-UTR used as an internal control. Panels F to L show real-
time RT-PCR data of JAG1 (F) and p27Kip1 (I) mRNA levels and immunoblotting of JAG1 (G), NICD (H), and p27Kip1 (J) protein levels in ischemic neural
progenitor cells delivered with mimic controls (control) or miR-124a mimics (miR-124a). Panels K and L show mRNA and protein levels, respectively, of
DLX2 in non-ischemic (control) and ischemic (MCAo) neural progenitor cells. Panels M and N show that nanoparticle-delivered miR-124a mimics into
ischemic neural progenitor cells (miR-124a) suppressed DLX2 mRNA (M) and protein (N) levels compared to the cells delivered with control mimics
(control). N=3 individual cultured SVZ cells/group, * p,0.05.
doi:10.1371/journal.pone.0023461.g005
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miRBase miRNA database v11.
For microarray data analysis, quality control of the total RNA
samples was assessed using UV spectrophotometry and agarose gel
electrophoresis. The samples were DNAse digested and low-
molecular weight (LMW) RNA was isolated by ultrafiltration
through YM-100 columns (Millipore, Billerica, MA, USA) and
subsequent purification using the RNeasy MinElute Clean-Up Kit
(Qiagen, Valencia, CA, USA). The LMW RNA samples were 39-
end labeled with biotin dye using the FlashTag
TM Biotin RNA
Labeling Kits (Genisphere, Hatfield, PA, USA). Labeled LMW
RNA samples were hybridized to the MicroRNA microarrays
according to conditions recommended in the Flash Taq RNA
labeling Kit manual. The microarrays were scanned on an Axon
Genepix 4000B scanner (Affymetrix Inc), and data were extracted
from images using GenePix V4.1 software. miRNA QC Tool
(Affymetrix Inc), a software for data summarization, Log2
transformation, normalization and quality control, was used.
Microarray data is MIAME compliant and the raw data has been
deposited in the Gene Expression Omnibus (GEO) database.
Bioinformatics analysis
To assay the gene targets of differentially expressed miRNAs, we
used three of the leading miRNA target prediction algorithms mi-
Randa (http://microrna.sanger.ac.uk/sequences/), PicTar (http://
pictar.mdc-berlin.de/), TargetScan (http://www.targetscan.org/). To
perform an enrichment analysis of predicted target genes of miRNAs
in biological pathways, DIANA-mirPath, a web-based application
[55], was used. This software analyses lists genes in the context of
known biological response and regulatory networks as well as other
higher-order response pathways.
In Situ Hybridization
In situ hybridization was performed according to a published
protocol [56]. Briefly, rats subjected to 7 day MCAo or sham
surgery were sacrificed under anesthesia by intracardial TBS-
paraformaldehyde perfusion. Coronal brain sections (20 mm thick)
from each rat were post-fixed and acetylated by incubating in
acetic anhydride/triethnolamine solution followed by washes in
16 PBS. The sections were incubated in hybridization solution
(50% formamide, 56SSC, 200 mg/mL yeast tRNA, 500 mg/mL
salmon sperm DNA, 0.4 g Roche blocking reagent, and 56
Denhardt’s solution) at room temperature for 2 h. The sections
were incubated overnight in hybridization solution containing
3 pmol of digoxin (DIG)-labeled LNA MiRCURY probes (Exiqon
Inc, Woburn, MA, USA) at below 220u predicted Tm value of the
probe used. The sections were washed at 55uC for 30 m in 16
SSC and for 10 min in 0.1 M Tris-HCl buffer (pH 7.5) and
incubated in the blocking solution (10% fetal calf serum in 0.1 M
Tris-HCl buffer) for 1 h at room temperature followed by labeling
with anti-DIG-FAB peroxidase (POD, Roche Applied Science,
Indianapolis, IN, USA) for 1 h at room temperature. The signals
were amplified using the Individual Indirect Tyramide Reagent
Kit (PerkinElmer Life Science, Waltham, Massachusetts, USA),
according to the protocol [56]. Alkaline phosphatase was used for
the detection of the miRNA signals.
For semiquantitative measurements of miR-124a signals, one
coronal sections/rat (N=5 rats) were employed. The SVZ area
was digitized with a 206objective (BX20 Olympus Optical) using
a 3-CCD color video camera (DXC-970 MD; Sony, Tokyo,
Japan) interfaced with a MCID image analysis system. The entire
SVZ area and areas with miR-124a signals in the SVZ were
measured, as described previously [57]. Data are presented as a
percentage of miR-124a signals within the SVZ.
Laser Capture Microdissection (LCM)
LCM was performed according to our published protocol [53],
[58]. Briefly, frozen brain coronal sections (8 mm) stored at 280uC
were immediately immersed in acetone for 2 min of fixation and
air-dried for 30 s. After a brief rinse with 0.1% diethylpyrocarbo-
nate-treated phosphate buffered saline, sections were stained with
propidium iodide dye (1:5000 dilution, Sigma Aldrich, Louis, MO,
USA) for 2 min and rinsed with phosphate buffered saline twice.
Sections were then air-dried under laminar flow for 10 min and
immediately used for LCM. Dense SVZ cells on sections stained
by propidium iodide were readily distinct from the ependymal cells
that have cilia along the lateral wall of the lateral ventricle and
from the adjacent striatal cells. In the non-ischemic rat, the dorsal
and ventral SVZ of the lateral wall was defined as a 20–30 mm-
wide zone approximately of 2–3 cell bodies immediately adjacent
to ependymal cells, whereas in the ischemic rat, the SVZ was
expanded to a 60–80 mm-wide zone. Propidium iodide-positive
cells within the SVZ were dissected with a Leica AS LMD System
(Leica Microsystems Inc). The excised cells fell into a collection
tube under gravity, ensuring contamination-free processing and
minimizing sample damage. Eppendorf tubes containing 40 mlo f
lysis buffer were stored at 280uC before miRNA isolation.
Approximately 1,000 cells were isolated in the SVZ from each
animal.
Quantification of mRNA by real-time qRT-PCR
RNAs extracted from the SVZ were reverse transcribed using
M-MLV reverse transcriptase (Invitrogen). 2 mg of RNA from
each sample was reverse transcribed at 42uC for 30 min with 1 mg
of Oligo
dT or specific primers, 56 first strand buffer, 100 mM
DTT, 10 mM dNTP, RNAsin (Invitrogen) and M-MLV. cDNAs
were checked for their optimum dilution in subsequent real-time
qRT-PCR reactions. PCR reaction mixtures included cDNAs in
optimum dilution, the SYBR Green qPCR Master mixture
(Applied Biosystem), 10 mM primers, in a total reaction volume
of 20 ml. Expression profiling was done with dissociation curves
using ABI 7000 (Applied Biosystem). Cycling parameters were
95uC for 4 min followed by 40 cycles of 20uC/s temperature
transition rate up to 95uC (30 s), 62uC (45 s), followed by melting
curve analysis. All reactions were performed in triplicate with
reference dye normalization (b-actin) and the median Ct (Cycle
threshold) value was used for analysis. Please see Table S3 for
detailed primer sequences. The relative abundance of each target
was calculated using the 22
DDCt method [59].
Quantification of mature miRNAs by real-time qRT-PCR
Individual reverse transcription and TaqManH microRNA
assays were performed on an Applied Biosystems 7000 Instrument
(Applied Biosystem). 15 mL Reverse transcription reactions
consisted of 1–10 ng Total RNA isolated with TRIzol (Qiagen),
5 U MultiScribe Reverse Transcriptase, 0.5 mM each dNTPs, 16
Reverse Transcription buffer, 4 U RNase Inhibitor, and nuclease
free water. Reverse transcription reactions were incubated at 16uC
for 30 min, 42uC for 30 min, 85uC for 5 min, and then stored at
4uC until use in TaqMan assays. 20 mL TaqMan real-time PCR
reactions consisted of 16TaqMan Universal PCR Master Mix No
AmpErase UNG, 16 TaqMan miRNA assay, 1.33 mLo f
undiluted cDNA, and nuclease free water. Each TaqMan assay
was done in triplicate for each sample tested. Relative quantities
were calculated using the 22
DDCt method with U6 snRNA
TaqMan miRNA control assay (Applied Biosystem) as the
endogenous control and calibrated to the wild type samples [59].
Three independent experiments were performed. Reactions were
run with the Standard 7000 default cycling protocol without the
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followed by 40 cycles of 95uC 15 sec, 60uC 1 min. Fluorescence
readings were collected during the 60uC step.
Nanoparticle-mediated miRNA Transfection
To efficiently introduce the miRNA into neural progenitor cells,
N-TER Nanoparticle Transfection System was employed [24].
Briefly, N-TER Peptide was diluted into water in a sterile tube and
incubated in a sonicating water bath at maximum output and
continuous power for 3–5 minutes. Then 5 mM miR-124a mimic
(mature sequence: UAAGGCACGCGGUGAAUGCC, Dharma-
con Inc, Chicago, IL, USA) or miRNA mimic control (Dharma-
con Inc) was diluted with N-TER Buffer in a sterile tube. The
Nanoparticle Formation Solutions were prepared by combining
the appropriate diluted miRNA solutions with diluted N-TER
Peptide solutions, and incubated the tubes containing the
Nanoparticle Formation Solutions (combined miRNA and N-
TER Peptide solutions) at room temperature for 20 minutes to
allow the nanoparticles to form. A solution of Nanoparticle
Formation Solutions was mixed in 1400 mL of growth medium.
This solution was added to the cells and slightly agitated to mix.
After 24 h at 37uC, the solution was removed from the cells and
replaced with 37uC growth medium or differentiation medium.
Neurosphere Assay
A neurosphere assay was employed to investigate the effect of
miR-124a on SVZ neural progenitor cells. The assay has been
widely used by us and others as a valuable tool for investigating the
biology of neural progenitor cells [53], [60], [61]. To examine the
effects of miRNAs on the proliferation of SVZ neural progenitor
cells, two methods were used [53], [61]. To analyze the formation
of secondary neurospheres, SVZ cells were gently triturated with a
fire-narrowed Pasteur pipette, spun down at 400 rpm for 3 min,
and then seeded at a density of 10 cells/ml in 96 well plates. The
number and size of neurospheres were measured at 7 days in vitro.
To analyze cell proliferation, single cells at a density of 10 cells/ml
were incubated in the growth medium for 3 days, and
bromodeoxyuridine (BrdU, 30 mg/ml, Sigma Aldrich), the thymi-
dine analog that is incorporated into the DNA of dividing cells
during S-phase, was added 18 h before the termination of
incubation. BrdU positive cells were measured (see blow for
quantification).
To examine the effects of miRNAs on SVZ cell differentiation,
neurospheres were plated directly onto laminin-coated glass
coverslips in DMEM/F-12 medium containing 2% fetal bovine
serum without bFGF and EGF, which is referred to as a
differentiation medium, in the presence of miRNA mimic. Every 4
days,halfof the medium was replaced with freshmedium.Incubation
was terminated 10 days after plating. The cells were processed to
mRNA analysis for identifying genotype of SVZ cells [53].
Immunocytochemistry and Quantification
Immunofluorescent staining was performed on cultured cells.
Mouse anti-BrdU (1:100; Boehringer Mannheim, Indianapolis,
IN, USA) was used as the primary antibody in the present study.
Cultured cells were fixed in 4% paraformaldehyde for 20 min at
room temperature. Nonspecific binding sites were blocked with
phosphate-buffered saline with 1% bovine serum albumin goat
serum for 1 h at room temperature. The cells were then incubated
with the primary antibodies listed above and with CY3-conjugated
secondary antibodies. Nuclei were counterstained with 4-,6-
diamidino-2-phenylindole (1:10,000, Vector Laboratories, Burlin-
game, CA, USA).
The number of BrdU-positive cells as well as total 4_,6-
diamidino-2-phenylindole (DAPI) nuclei was counted under a 406
objective (IX71; Olympus Optical, Tokyo, Japan), and the
percentage of BrdU/DAPI was determined. For all measurements,
we counted at least 500 cells from three wells/group (n=3
individual cultured cells).
Luciferase activity assay
There are at least two predicated target sites for miR-124a in the
entire 39-UTR of Jagged-1 (JAG1) (www.targetscan.org). As we had
difficulty to amplify the full 39-UTR of JAG1, a 286 bp fragment of
JAG1 39-UTR from the rat was amplified by PCR using the primers
59-CGACTAGTGGTTTTATGATGACGTA-39 and 59-CGAAG-
CTT GAATGATGTTTTAAGGC-39. The fragment, which con-
tains a broadly conserved motif in the vertebrates for miR-124a (www.
targetscan. ) was cloned downstream of the luciferase gene in
pMIR-REPORT luciferase vector (Ambion, Austin, TX, USA). This
construct, named pMIR-JAG1, was used for transfection in 3T3 cell
line (ATCC, Manassas, VA, USA). To generate a mutant containing a
deletion of the miR-124a target sequence, PCR and appropriate
primer sets (F: 59-GACGTA CAAGTAGTTCTGTATTTGAA-
ATGCAGCTCAGAACC and R: 59-GGTTCTGAGCTGCA TT-
TCAAATACAGAACT ACTTGTACGTC) were used to amplify
JAG1-mutant. PCR product was subcloned into the CMV promoter
luciferase reporter pMIR-REPORT( A m b i o n )u s i n gS p e Ia n dH i n d
III restriction enzymes (Invitrogen).
3T3 cells were cultured in 96 well plates and each transfected
with 0.15 mg of either pMIR-JAG1 (pMIR-JAG1 mu) or pMIR-
REPORT together with 0.05 mg of pRL-TK vector (Promega,
Madison, WI, USA) containing Renilla luciferase and miR-124a
or negative control miRNA mimics. Transfection was done using
Lipofectamine 2000 and Opti-MEM I reduced serum medium
(Invitrogen). Forty-eight hours after transfection, firefly and
Renilla luciferase activity were measured using Dual luciferase
assay kit (Promega) with plate reader (Perkin Elmer, Waltham,
MA, USA). The results were expressed as relative activity. Each
transfection was repeated twice in triplicate.
SDS-PAGE and Western blot
Cells were lysed in RIPA buffer, and lysate was sonicated and then
centrifuged for 10 min at 12,000 rpm to remove cell debris. Protein
concentrationswere determined usinga BCA assay(Thermo Scientific,
Waltham, MA, USA). Equal amounts of proteins were then separated
by SDS-PAGE and transferred to a nitrocellulose membrane.
Membrane was probed with an appropriate primary antibody and a
secondary antibody conjugated to horseradish peroxidase. The
following antibodies were utilized: b-actin (1:10,000 dilution, Milli-
pore), distalless (DLX)2 (1:500 dilution, Chemicon), NICD (1:500
dilution, Cell Signaling, Danvers, MA, USA), JAG1 (1:500 dilution,
Chemicon), p27Kip1 (1:500 dilution, Santa Cruz). Proteins were
visualized by enhanced chemiluminescence (Thermo Fisher Scientific,
Rockford, IL, USA). Three independent experiments were performed
and one representative result was shown.
Statistical Analysis. The data are presented as mean 6 SE.
Independent sample t-test was used for two-group comparisons from
the non-MCAo and MCAo samples. One-way analysis of variance
followed by Student-Newman-Keuls test was performed for multiple
sample analysis. A value of p,0.05 was taken as significant.
Supporting Information
Figure S1 Cluster diagram for detected microRNA from
Affymetrix microRNA microarray experiment. MiRNA probe
expression values (Log2 transformed & normalized microarray probe
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orgintensities) of detected miRNA in either MCAo non-MCAo samples
were median centered. Each column represents a single sample, and
each row represents a single miRNA probe. Green squares represent
lower than median levels of gene expression; black squares represent
median levels of gene expression; red squares represent higher than
median levels of gene expression. Legend units: 1.0=differs from
median probe intensity by one log 2 unit (2-fold).
(TIF)
Table S1 miRNA gene profiles in cultured neural progenitor
cells isolated from the SVZ in rats subject to 7 days of MCAo.
(XLS)
Table S2 Biologic functions associated with commonly upregulated
and downregulated miRNAs in neural progenitor cells after MCAo.
(XLS)
Table S3 Primer sequences.
(XLS)
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